- Trials with a EudraCT protocol (44)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
44 result(s) found for: Hidradenitis Suppurativa.
Displaying page 1 of 3.
EudraCT Number: 2006-005297-48 | Sponsor Protocol Number: HUM 06-0023 | Start Date*: 2007-03-20 | |||||||||||
Sponsor Name:University of Copenhagen, Roskilde, Department of Dermatology | |||||||||||||
Full Title: Adalimumab s.c. for the treatment of patients with hidradenitis suppurativa – clinical efficacy, safety and tolerability - SOPHISTICATE | |||||||||||||
Medical condition: Patients with hidradenitis suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004731-39 | Sponsor Protocol Number: CCJM112X2202 | Start Date*: 2015-10-05 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized, double-blind, placebo controlled, multiple dose study to evaluate the clinical efficacy, safety, tolerability, dose relation, pharmacokinetics and pharmacodynamics of CJM112 in modera... | |||||||||||||
Medical condition: Chronic hidradenitis suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) DK (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002321-20 | Sponsor Protocol Number: HIDRA04 | Start Date*: 2015-09-01 | |||||||||||
Sponsor Name:Hellenic Institute for the Study of Sepsis | |||||||||||||
Full Title: A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED CLINICAL TRIAL OF THE SAFETY AND EFFICACY OF MABp1, A HUMAN ANTIBODY TARGETING INTERLEUKIN-1ALPHA, IN PATIENTS WITH HIDRADENITIS SUPPURATIVA | |||||||||||||
Medical condition: HIDRADENITIS SUPPURATIVA/ACNE INVERSA | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003478-98 | Sponsor Protocol Number: M12-555 | Start Date*: 2012-12-19 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Phase 3 Open-Label Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Hidradenitis Suppurativa. | |||||||||||||
Medical condition: Hidradenitis Suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) NL (Completed) HU (Completed) GR (Completed) DE (Completed) DK (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004179-42 | Sponsor Protocol Number: HS0005 | Start Date*: 2021-07-06 | |||||||||||
Sponsor Name:UCB Biopharma SRL | |||||||||||||
Full Title: A Phase 3, Open-Label, Parallel Group, Multicenter, Extension Study Evaluating the Long-Term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa | |||||||||||||
Medical condition: Hidradenitis Suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) DE (Ongoing) CZ (Ongoing) GR (Ongoing) HU (Completed) BG (Ongoing) BE (Completed) IT (Ongoing) NL (Ongoing) DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000049-42 | Sponsor Protocol Number: UNI50007-201 | Start Date*: 2021-09-16 | |||||||||||
Sponsor Name:Zealand University Hospital (Universitetshospital Sjælland) | |||||||||||||
Full Title: Orismilast for the treatment of mild to severe hidradenitis suppurativa; A phase 2, open-label, proof of concept trial comparing the response to an oral tablet formulation of orismilast in adult pa... | |||||||||||||
Medical condition: Hidradenitis suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001566-28 | Sponsor Protocol Number: UCDCRC/16/002 | Start Date*: 2017-01-11 | |||||||||||
Sponsor Name:University College Dublin | |||||||||||||
Full Title: Usage of Omics Technology for Identification of Critical Mediators and Pathways in Patients with Hidradenitis Suppurativa | |||||||||||||
Medical condition: Hidradenitis Suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002757-30 | Sponsor Protocol Number: CCFZ533H12201BC | Start Date*: 2019-03-28 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized, subject and investigator blinded, placebo controlled and multi-center platform study, to assess efficacy and safety of different investigational drugs in patients with moderate to sev... | |||||||||||||
Medical condition: Hidradenitis suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) HU (Trial now transitioned) DK (Completed) NL (Completed) CZ (Completed) BE (Ongoing) ES (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005145-12 | Sponsor Protocol Number: HIDRA03 | Start Date*: 2012-02-08 | |||||||||||
Sponsor Name:University of Athens, Medical School | |||||||||||||
Full Title: A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED CLINICAL TRIAL OF THE SAFETY AND EFFICACY OF ANAKINRA IN PATIENTS WITH HIDRADENITIS SUPPURATIVA (PROTOCOL: HIDRA03) | |||||||||||||
Medical condition: Hidradenitis suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005587-55 | Sponsor Protocol Number: 1368-0067 | Start Date*: 2021-06-03 | |||||||||||
Sponsor Name:Boehringer Ingelheim France | |||||||||||||
Full Title: An open-label, long-term extension trial of spesolimab treatment in adult patients with Hidradenitis Suppurativa (HS) | |||||||||||||
Medical condition: Hidradenitis Suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) HU (Ongoing) DE (Completed) NO (Ongoing) CZ (Ongoing) NL (Ongoing) BE (Ongoing) IT (Ongoing) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002550-23 | Sponsor Protocol Number: HS0003 | Start Date*: 2020-04-24 | |||||||||||
Sponsor Name:UCB Biopharma SRL | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa | |||||||||||||
Medical condition: Hidradenitis Suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GR (Completed) BE (Completed) NL (Completed) DK (Completed) ES (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003672-40 | Sponsor Protocol Number: 1368-0052 | Start Date*: 2021-03-02 | |||||||||||
Sponsor Name:Boehringer Ingelheim France | |||||||||||||
Full Title: Randomized, double-blind, placebo-controlled, study of spesolimab in patients with moderate or severe hidradenitis suppurativa | |||||||||||||
Medical condition: hidradenitis suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) HU (Ongoing) CZ (Completed) BE (Completed) NL (Completed) DE (Completed) GR (Prematurely Ended) IT (Completed) ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005928-38 | Sponsor Protocol Number: M1095-HS-201 | Start Date*: 2022-08-23 | |||||||||||
Sponsor Name:MoonLake Immunotherapeutics AG | |||||||||||||
Full Title: Phase 2, randomized, parallel-group, double-blind, placebo-controlled study of sonelokimab in patients with active moderate to severe hidradenitis suppurativa | |||||||||||||
Medical condition: Active moderate to severe hidradenitis suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) NL (Completed) BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005713-13 | Sponsor Protocol Number: 21102 | Start Date*: 2022-08-16 | |||||||||||
Sponsor Name:ACELYRIN, INC. | |||||||||||||
Full Title: A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Moderate to Severe Hidradenitis Suppurativa | |||||||||||||
Medical condition: Hidradenitis Suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Ongoing) HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005405-67 | Sponsor Protocol Number: 200602235 | Start Date*: 2007-03-29 | |||||||||||
Sponsor Name:LABCATAL [...] | |||||||||||||
Full Title: Etude de l'efficacité et de la tolérance du L35 versus placebo dans le traitement de l'hidradénite suppurée (Maladie de Verneuil) | |||||||||||||
Medical condition: Hidradénite suppurée (Maladie de Verneuil) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002607-19 | Sponsor Protocol Number: 77474462HDS2001 | Start Date*: 2021-10-07 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 2a/2b, Multicenter, Randomized, Placebo and Active Comparator-controlled, Double-Blind, Dose-ranging Study to Evaluate the Safety and Efficacy of Bermekimab (JNJ-77474462) for the Treatment... | |||||||||||||
Medical condition: Moderate to Severe Hidradenitis Suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) NL (Prematurely Ended) ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004108-33 | Sponsor Protocol Number: M20-262 | Start Date*: 2022-03-09 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Phase 2 Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of Lutikizumab (ABT-981) in Adult Subjects with Moderate to Severe Hidradenitis Suppurat... | |||||||||||||
Medical condition: Hidradenitis Suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) DE (Completed) GR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001440-99 | Sponsor Protocol Number: ANB019-208 | Start Date*: 2021-08-25 | |||||||||||
Sponsor Name:AnaptysBio Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects with Hidradenitis Suppurativa | |||||||||||||
Medical condition: Hidradenitis Suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004587-38 | Sponsor Protocol Number: M10-467 | Start Date*: 2009-06-03 | |||||||||||
Sponsor Name:Abbott GmbH & Co. KG | |||||||||||||
Full Title: A Phase 2 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Chronic Hidradenitis Suppurativa | |||||||||||||
Medical condition: Hidradenitis Suppurativa (HS) is a painful, chronic, skin disease characterized by recurrent inflamed nodules, abscesses, and fistulas, which may heal with scarring. The most commonly involved ana... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) NL (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003400-20 | Sponsor Protocol Number: M11-313 | Start Date*: 2012-04-12 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Phase 3 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Hidradenitis Suppurativa | |||||||||||||
Medical condition: Hidradenitis Suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.